We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLX icon
9851
VanEck Steel ETF
SLX
$173M
$280K ﹤0.01%
+5,670
New +$344K
NAPA
9852
PUT
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$280K ﹤0.01%
13,300
-18,400
-58% -$361K
SMCP
9853
DELISTED
AlphaMark Actively Managed Small Cap ETF
SMCP
$280K ﹤0.01%
11,876
-1,271
-10% -$32.4K
CWAN
9854
DELISTED
Clearwater Analytics
CWAN
$279K ﹤0.01%
+23,162
New +$374K
DWMF icon
9855
WisdomTree International Multifactor Fund
DWMF
$34.4M
$279K ﹤0.01%
11,872
-5,895
-33% -$145K
HI
9856
PUT
DELISTED
Hillenbrand
HI
$279K ﹤0.01%
6,800
-4,300
-39% -$180K
SABA
9857
Saba Capital Income & Opportunities Fund II
SABA
$220M
$279K ﹤0.01%
+31,589
New +$293K
SHYF
9858
CALL
DELISTED
The Shyft Group
SHYF
$279K ﹤0.01%
15,000
+2,400
+19% +$58.8K
NSLR
9859
PUT
Neostellar Capital Corp
NSLR
$278M
$279K ﹤0.01%
43,596
+2,508
+6% +$19.4K
KNTE
9860
CALL
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$279K ﹤0.01%
22,100
-3,000
-12% -$27.9K
ATHX
9861
DELISTED
Athersys, Inc. Common Stock
ATHX
$279K ﹤0.01%
42,920
+32,164
+299% +$356K
CTSO icon
9862
Cytosorbents Corp
CTSO
$25.1M
$278K ﹤0.01%
126,898
+104,296
+461% +$239K
GNL icon
9863
PUT
Global Net Lease
GNL
$2.03B
$278K ﹤0.01%
19,600
-24,600
-56% -$352K
QNCX icon
9864
CALL
Quince Therapeutics
QNCX
$34.6M
$278K ﹤0.01%
626
-184
-23% -$130K
CTEV
9865
PUT
Claritev Corp
CTEV
$646M
$278K ﹤0.01%
1,268
-455
-26% -$90K
POLY
9866
CALL
DELISTED
Plantronics, Inc.
POLY
$278K ﹤0.01%
7,000
-2,600
-27% -$103K
BATT icon
9867
CALL
Amplify Lithium & Battery Technology ETF
BATT
$124M
$277K ﹤0.01%
+18,900
New +$286K
FF icon
9868
CALL
Future Fuel
FF
$245M
$277K ﹤0.01%
38,100
+27,800
+270% +$233K
PCEF icon
9869
Invesco CEF Income Composite ETF
PCEF
$820M
$277K ﹤0.01%
14,614
-19,913
-58% -$403K
SHOO icon
9870
PUT
Steven Madden
SHOO
$3.45B
$277K ﹤0.01%
8,600
+400
+5% +$15.2K
SLI
9871
PUT
Standard Lithium
SLI
$587M
$277K ﹤0.01%
65,400
-43,000
-40% -$254K
USL icon
9872
PUT
United States 12 Month Oil Fund,
USL
$45.7M
$277K ﹤0.01%
7,000
-7,600
-52% -$306K
HUYA
9873
PUT
Huya Inc
HUYA
$529M
$276K ﹤0.01%
71,200
-39,700
-36% -$166K
IAT icon
9874
iShares US Regional Banks ETF
IAT
$693M
$276K ﹤0.01%
+5,608
New +$299K
PAYS icon
9875
Paysign
PAYS
$744M
$276K ﹤0.01%
181,619
-27,103
-13% -$44.9K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.